1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. Genome Editing Market, by Technology
6.1. Introduction
6.2. Antisense
6.3. Crispr
6.4. Talen
6.5. ZFN

7. Genome Editing Market, by Application
7.1. Introduction
7.2. Cell Line Engineering
7.3. Genetic Engineering
7.3.1. Animal Genetic Engineering
7.3.2. Plant Genetic Engineering

8. Genome Editing Market, by End User
8.1. Introduction
8.2. Academic & Government Research Institutes
8.3. Biotechnology & Pharmaceutical Companies
8.4. Contract Research Organizations

9. California Genome Editing Market

10. Florida Genome Editing Market

11. Illinois Genome Editing Market

12. New York Genome Editing Market

13. Ohio Genome Editing Market

14. Pennsylvania Genome Editing Market

15. Texas Genome Editing Market

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. Abcam PLC
17.2. AgriGenome Labs Pvt. Ltd.
17.3. Beam Therapeutics Inc
17.4. Biocompare
17.5. CRISPR Therapeutics AG
17.6. Danaher Corp.
17.7. Editas Medicine, Inc.
17.8. GenScript Biotech Corporation
17.9. Inari Agriculture, Inc.
17.10. Inscripta, Inc.
17.11. Lonza Group Ltd
17.12. Meissa Vaccines, Inc.
17.13. Merck KGaA,
17.14. New England Biolabs, Inc.
17.15. OriGene Technologies, Inc.
17.16. PerkinElmer Inc.
17.17. Regeneron Pharmaceuticals, Inc.
17.18. Sangamo Therapeutics, Inc
17.19. TC BioPharm Limited
17.20. Thermo Fisher Scientific Inc
17.21. Tracxn Technologies Private Limited
17.22. Verve Therapeutics, Inc.,

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES GENOME EDITING MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES GENOME EDITING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. UNITED STATES GENOME EDITING MARKET: MARKET DYNAMICS
FIGURE 4. UNITED STATES GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (%)
FIGURE 5. UNITED STATES GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2026
FIGURE 7. UNITED STATES GENOME EDITING MARKET SIZE, BY ANTISENSE, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES GENOME EDITING MARKET SIZE, BY ANTISENSE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 9. UNITED STATES GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2026 (USD MILLION)
FIGURE 10. UNITED STATES GENOME EDITING MARKET SIZE, BY CRISPR, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 11. UNITED STATES GENOME EDITING MARKET SIZE, BY TALEN, 2018-2026 (USD MILLION)
FIGURE 12. UNITED STATES GENOME EDITING MARKET SIZE, BY TALEN, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 13. UNITED STATES GENOME EDITING MARKET SIZE, BY ZFN, 2018-2026 (USD MILLION)
FIGURE 14. UNITED STATES GENOME EDITING MARKET SIZE, BY ZFN, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 15. UNITED STATES GENOME EDITING MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 16. UNITED STATES GENOME EDITING MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES GENOME EDITING MARKET SIZE, BY APPLICATION, 2026
FIGURE 18. UNITED STATES GENOME EDITING MARKET SIZE, BY CELL LINE ENGINEERING, 2018-2026 (USD MILLION)
FIGURE 19. UNITED STATES GENOME EDITING MARKET SIZE, BY CELL LINE ENGINEERING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 20. UNITED STATES GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2026 (USD MILLION)
FIGURE 21. UNITED STATES GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 22. UNITED STATES GENOME EDITING MARKET SIZE, BY ANIMAL GENETIC ENGINEERING, 2018-2026 (USD MILLION)
FIGURE 23. UNITED STATES GENOME EDITING MARKET SIZE, BY ANIMAL GENETIC ENGINEERING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 24. UNITED STATES GENOME EDITING MARKET SIZE, BY PLANT GENETIC ENGINEERING, 2018-2026 (USD MILLION)
FIGURE 25. UNITED STATES GENOME EDITING MARKET SIZE, BY PLANT GENETIC ENGINEERING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 26. UNITED STATES GENOME EDITING MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 27. UNITED STATES GENOME EDITING MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES GENOME EDITING MARKET SIZE, BY END USER, 2026
FIGURE 29. UNITED STATES GENOME EDITING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, 2018-2026 (USD MILLION)
FIGURE 30. UNITED STATES GENOME EDITING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 31. UNITED STATES GENOME EDITING MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2018-2026 (USD MILLION)
FIGURE 32. UNITED STATES GENOME EDITING MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 33. UNITED STATES GENOME EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2026 (USD MILLION)
FIGURE 34. UNITED STATES GENOME EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 35. UNITED STATES GENOME EDITING MARKET: FPNV POSITIONING MATRIX
FIGURE 36. UNITED STATES GENOME EDITING MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 37. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES GENOME EDITING MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES GENOME EDITING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES GENOME EDITING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES GENOME EDITING MARKET SIZE, BY ANTISENSE, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES GENOME EDITING MARKET SIZE, BY CRISPR, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES GENOME EDITING MARKET SIZE, BY TALEN, BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES GENOME EDITING MARKET SIZE, BY ZFN, BY STATE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES GENOME EDITING MARKET SIZE, BY CELL LINE ENGINEERING, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES GENOME EDITING MARKET SIZE, BY ANIMAL GENETIC ENGINEERING, BY STATE, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES GENOME EDITING MARKET SIZE, BY PLANT GENETIC ENGINEERING, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES GENOME EDITING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES GENOME EDITING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY STATE, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES GENOME EDITING MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES GENOME EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY STATE, 2018-2026 (USD MILLION)
TABLE 18. UNITED STATES GENOME EDITING MARKET: SCORES
TABLE 19. UNITED STATES GENOME EDITING MARKET: BUSINESS STRATEGY
TABLE 20. UNITED STATES GENOME EDITING MARKET: PRODUCT SATISFACTION
TABLE 21. UNITED STATES GENOME EDITING MARKET: RANKING
TABLE 22. UNITED STATES GENOME EDITING MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 23. UNITED STATES GENOME EDITING MARKET: MERGER & ACQUISITION
TABLE 24. UNITED STATES GENOME EDITING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 25. UNITED STATES GENOME EDITING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 26. UNITED STATES GENOME EDITING MARKET: INVESTMENT & FUNDING
TABLE 27. UNITED STATES GENOME EDITING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 28. UNITED STATES GENOME EDITING MARKET: LICENSE & PRICING

Companies Mentioned

Abcam PLC
AgriGenome Labs Pvt. Ltd.
Beam Therapeutics Inc
Biocompare
CRISPR Therapeutics AG
Danaher Corp.
Editas Medicine, Inc.
GenScript Biotech Corporation
Inari Agriculture, Inc.
Inscripta, Inc.
Lonza Group Ltd
Meissa Vaccines, Inc.
Merck KGaA,
New England Biolabs, Inc.
OriGene Technologies, Inc.
PerkinElmer Inc.
Regeneron Pharmaceuticals, Inc.
Sangamo Therapeutics, Inc
TC BioPharm Limited
Thermo Fisher Scientific Inc
Tracxn Technologies Private Limited
Verve Therapeutics, Inc.,